Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions.

Van Deerlin VM, Sleiman PM, Martinez-Lage M, Chen-Plotkin A, Wang LS, Graff-Radford NR, Dickson DW, Rademakers R, Boeve BF, Grossman M, Arnold SE, Mann DM, Pickering-Brown SM, Seelaar H, Heutink P, van Swieten JC, Murrell JR, Ghetti B, Spina S, Grafman J, Hodges J, Spillantini MG, Gilman S, Lieberman AP, Kaye JA, Woltjer RL, Bigio EH, Mesulam M, Al-Sarraj S, Troakes C, Rosenberg RN, White CL 3rd, Ferrer I, Lladó A, Neumann M, Kretzschmar HA, Hulette CM, Welsh-Bohmer KA, Miller BL, Alzualde A, Lopez de Munain A, McKee AC, Gearing M, Levey AI, Lah JJ, Hardy J, Rohrer JD, Lashley T, Mackenzie IR, Feldman HH, Hamilton RL, Dekosky ST, van der Zee J, Kumar-Singh S, Van Broeckhoven C, Mayeux R, Vonsattel JP, Troncoso JC, Kril JJ, Kwok JB, Halliday GM, Bird TD, Ince PG, Shaw PJ, Cairns NJ, Morris JC, McLean CA, DeCarli C, Ellis WG, Freeman SH, Frosch MP, Growdon JH, Perl DP, Sano M, Bennett DA, Schneider JA, Beach TG, Reiman EM, Woodruff BK, Cummings J, Vinters HV, Miller CA, Chui HC, Alafuzoff I, Hartikainen P, Seilhean D, Galasko D, Masliah E, Cotman CW, Tuñón MT, Martínez MC, Munoz DG, Carroll SL, Marson D, Riederer PF, Bogdanovic N, Schellenberg GD, Hakonarson H, Trojanowski JQ, Lee VM.

Nat Genet. 2010 Mar;42(3):234-9. doi: 10.1038/ng.536. Epub 2010 Feb 14.

2.

TMEM106B a novel risk factor for frontotemporal lobar degeneration.

van der Zee J, Van Broeckhoven C.

J Mol Neurosci. 2011 Nov;45(3):516-21. doi: 10.1007/s12031-011-9555-x. Epub 2011 May 26. Review.

3.

Human genetics as a tool to identify progranulin regulators.

Nicholson AM, Finch NA, Rademakers R.

J Mol Neurosci. 2011 Nov;45(3):532-7. doi: 10.1007/s12031-011-9554-y. Epub 2011 May 28. Review.

4.

What we know about TMEM106B in neurodegeneration.

Nicholson AM, Rademakers R.

Acta Neuropathol. 2016 Nov;132(5):639-651. Epub 2016 Aug 20. Review.

PMID:
27543298
5.

Frontotemporal lobar degeneration: diversity of FTLD lesions.

Seilhean D, Bielle F, Plu I, Duyckaerts C.

Rev Neurol (Paris). 2013 Oct;169(10):786-92. doi: 10.1016/j.neurol.2013.07.015. Epub 2013 Sep 12. Review.

PMID:
24035575
6.

Recent advances in the genetics of the ALS-FTLD complex.

Morris HR, Waite AJ, Williams NM, Neal JW, Blake DJ.

Curr Neurol Neurosci Rep. 2012 Jun;12(3):243-50. doi: 10.1007/s11910-012-0268-5. Review.

PMID:
22477152
7.

[Clinicopathological features of sporadic frontotemporal lobar degeneration with TDP-43-positive inclusions].

Yokota O.

Rinsho Shinkeigaku. 2010 Nov;50(11):1018-21. Review. Japanese.

PMID:
21921551
8.

The genetics of frontotemporal lobar degeneration.

Rademakers R, Hutton M.

Curr Neurol Neurosci Rep. 2007 Sep;7(5):434-42. Review.

PMID:
17764635
9.

Frontotemporal Lobar Degeneration.

Premi E, Padovani A, Borroni B.

Adv Exp Med Biol. 2012;724:114-27. doi: 10.1007/978-1-4614-0653-2_9. Review.

PMID:
22411238
10.

Progranulin and TDP-43: mechanistic links and future directions.

Kumar-Singh S.

J Mol Neurosci. 2011 Nov;45(3):561-73. doi: 10.1007/s12031-011-9625-0. Epub 2011 Aug 24. Review.

11.

[The molecular pathology of frontotemporal lobar degeneration].

Fujishiro H, Hasegawa M, Arai T.

Seishin Shinkeigaku Zasshi. 2010;112(4):313-24. Review. Japanese.

PMID:
20496755
12.

Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD).

Lourenco GF, Janitz M, Huang Y, Halliday GM.

Neurobiol Dis. 2015 Oct;82:445-454. doi: 10.1016/j.nbd.2015.07.011. Epub 2015 Jul 26. Review.

PMID:
26220395
13.

The molecular genetics and neuropathology of frontotemporal lobar degeneration: recent developments.

Mackenzie IR, Rademakers R.

Neurogenetics. 2007 Nov;8(4):237-48. Epub 2007 Sep 6. Review.

PMID:
17805587
14.

Novel types of frontotemporal lobar degeneration: beyond tau and TDP-43.

Mackenzie IR, Neumann M, Cairns NJ, Munoz DG, Isaacs AM.

J Mol Neurosci. 2011 Nov;45(3):402-8. doi: 10.1007/s12031-011-9551-1. Epub 2011 May 21. Review.

PMID:
21603977
15.

Genetics of FTLD: overview and what else we can expect from genetic studies.

Pottier C, Ravenscroft TA, Sanchez-Contreras M, Rademakers R.

J Neurochem. 2016 Aug;138 Suppl 1:32-53. doi: 10.1111/jnc.13622. Review.

16.

The complex aetiology of frontotemporal lobar degeneration.

Pickering-Brown SM.

Exp Neurol. 2007 Jul;206(1):1-10. Epub 2007 Mar 24. Review.

PMID:
17509568
17.

Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia.

van Swieten JC, Heutink P.

Lancet Neurol. 2008 Oct;7(10):965-74. doi: 10.1016/S1474-4422(08)70194-7. Epub 2008 Sep 2. Review.

PMID:
18771956
18.

TDP-43 and frontotemporal dementia.

Hu WT, Grossman M.

Curr Neurol Neurosci Rep. 2009 Sep;9(5):353-8. Review.

PMID:
19664364
19.

[Clinical and pathological spectrum of TDP-43 associated ALS].

Onodera O, Yokoseki A, Tan CF, Ishihara T, Nishiira Y, Toyoshima Y, Kakita A, Nishizawa M, Takahashi H.

Rinsho Shinkeigaku. 2010 Nov;50(11):940-2. Review. Japanese.

PMID:
21921519
20.

Update on recent molecular and genetic advances in frontotemporal lobar degeneration.

Bigio EH.

J Neuropathol Exp Neurol. 2008 Jul;67(7):635-48. doi: 10.1097/NEN.0b013e31817d751c. Review.

Supplemental Content

Support Center